Sensovisc gel for knee osteoarthritis pain
Part of Bones, joints & muscles clinical trials.
This study tests a gel called Sensovisc to see if it can reduce pain in people with knee osteoarthritis. If you have had knee pain for more than 3 months and have stage 2 or 3 osteoarthritis, this trial might help you find relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had knee pain (in one or both knees) for more than 3 months.
- Your doctor has confirmed knee osteoarthritis at stage 2 or 3 based on an X-ray taken in the last year.
- You have had pain at rest (at least 40 mm on a scale of 0–100) for at least 15 days in the past month.
- Your body mass index (BMI) is 40 or less.
- You have not had surgery, arthroscopy, or certain knee injections in the past 1 to 6 months.
- You do not have other causes of knee pain like rheumatoid arthritis, gout, or a recent ligament injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a single injection of hyaluronic acid (a gel-like substance that cushions the knee joint) can improve pain and function in people with knee osteoarthritis. It aims to see if one shot provides long-term relief without the need for repeated injections.
This trial tests a gel injection (Sensovisc) for hip arthritis pain. It aims to see if the gel can reduce pain and improve function in people with moderate hip osteoarthritis.
This study tests if a single injection of a special gel combined with a rehabilitation program can reduce pain and improve knee function in active adults with knee osteoarthritis. It aims to help people get back to sports.
This study looks at how knee pain from osteoarthritis affects your daily life and health. You'll use a topical anti-inflammatory gel and answer questions by text or email for two months.
This trial compares two treatments for knee osteoarthritis: a shockwave therapy and a gel containing chitosan nanoparticles (tiny particles) applied with ultrasound. It uses AI to detect changes in knee tissues. The goal is to find which treatment better reduces pain and improves function.
This trial tests whether applying bee venom gel with ultrasound (phonophoresis) can reduce pain and improve mobility in people with knee osteoarthritis. It may be an option if you have moderate to severe knee pain and haven't had recent knee surgery or injections.
Hear when a new Osteo Arthritis of the Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.